Delivery Order SPE2DB22D3016-SPE2DB25FAZZ6
Award Date
6/23/25
Potential Completion Date
7/15/25
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide TECENTRIQ 840 MG/14 ML VIAL 14ML, a medical supply. The contract is a firm-fixed-price delivery order with a ceiling value of $8,504.62 and a period of performance through July 16, 2025. The contract is not set-aside and is funded by the DLA, which is the Defense agency responsible for medical supply chain management. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML medical products. The contract has a ceiling value of $7,857.74 and a performance period running through January 18, 2024. The contract is a firm fixed-price delivery order, and does not have a set-aside designation. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., one of the...
This federal contract award, valued at $17,009.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TECENTRIQ 840 MG/14 ML VIAL 14ML, a specialty medication, to support military healthcare programs. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at...
This is a delivery order (SPE2DB20D1100|SPE2DB24FA7E7) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The order is for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML, a specialty pharmaceutical product, at a firm fixed price of $16,032.60. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $34,018.40 contract is for the supply of 840 mg/14 ml vials of the cancer medication Tecentriq. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies in support of military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 840 mg/14 ml vials of the cancer medication Tecentriq. The $8,504.62 firm fixed-price delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides comprehensive global pharmaceutical support to military healthcare programs. The contract is not...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TECENTRIQ HYBREZA 1,875 MG 15ML, a medical product, with a ceiling value of $6,297.24 and a period of performance ending on July 16, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $7,857.74 firm fixed price delivery order is for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML, a pharmaceutical product. The contract has a completion date of January 23, 2024 and was awarded on December 29, 2023. No set-aside designations were used. Amerisourcebergen Drug Corp is a prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,594.50, is a delivery order for the supply of Tecentriq Hybreza 1,875 mg 15 ml, a pharmaceutical product. The contract has an ultimate completion date of April 3, 2025 and a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,824.28, is for the delivery of the specialty medication TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The contract has a firm fixed price pricing type and an ultimate completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...